Home >> Life Sciences >> Pharmaceuticals >> General Pharmaceuticals

Global Sports Medicine Market Outlook (2014-2022)

Published: Jun-2015 | Format: PDF | Stratistics MRC | Number of pages: 90 | Code: MRS - 25451


The Global Sports Medicine Market is accounted $31.5 billion in 2014 and is expected to reach $53.6 billion in 2022 at a Compound Annual Growth Rate of 6.8%. Sports medicine is about preventing and treating the athletes and any other people indulged in physical activities from injuries. The Sports Medicine market is the sub set of the orthopedic market. Some of the key factors driving the market are increasing number of cases of sports injuries, gaining popularity of western sports and growing economies to raise the budget allotment for sports. Whereas factors such as lack of trained professionals and cost of certain products are likely to restraint the market growth. Insurance is posing challenge to sports medicine as it would not cover the sports injuries and reimbursement.

The Global Sports Medicine Market is segmented by procedure type, product type, application and geography. By procedure, it is categorized to Cartilage Reconstruction and Repair, Ligament Reconstruction and Repair, Bone Reconstruction & Repair and Surgery. On the basis of product type, it is segmented to orthopedic products and Recovery products. Orthopedic products are sub categorized to Arthroscopy Devices, Fracture Repair Devices, Artificial implants, Orthobiologics and Soft Tissue Fixation Devices. Recovery Products are sub categorized to Braces, Thermotherapy, Performance Monitoring Devices and Accessories. By application, it is segmented to Shoulder, Knee, Hand and Wrist, Elbow, Foot and Ankle, Hip, Groin and Spine. By geography, it is segmented to North America, Europe, Asia Pacific, and Rest of the World.

Some of the key players in the Sports Medicine Market are Arthrex, Biomet Inc., Arthrocare, Conmed Corporation, Stryker Corporation, Otto Bock Healthcare, DJO Global, Zimmer Holdings Inc., Smith & Nephews and Xiros.

WHAT OUR REPORT OFFERS:

  • Market share assessments for the regional and country level segments
  • Market share analysis of the top industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 8 years of all the mentioned segments, sub segments and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Table of Content

1 EXECUTIVE SUMMARY

2 PREFACE
2.1 Abstract
2.2 Research Scope
2.3 Research Methodology
2.4 Research Sources

3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats

4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 GLOBAL SPORTS MEDICINE MARKET, BY PROCEDURE
5.1 Cartilage Reconstruction and Repair
5.2 Ligament Reconstruction and Repair
5.3 Bone Reconstruction & Repair
5.4 Surgery

6 GLOBAL SPORTS MEDICINE MARKET, BY PRODUCT TYPE
6.1 Orthopedic Products
6.1.1 Arthroscopy Devices
6.1.2 Repair Devices
6.1.3 Artificial implants
6.1.4 Orthobiologics
6.1.5 Soft Tissue Fixation Devices
6.2 Recovery Products
6.2.1 Braces
6.2.2 Thermotherapy
6.2.3 Performance Monitoring Devices
6.2.4 Accessories

7 GLOBAL SPORTS MEDICINE MARKET, BY APPLICATION
7.1 Shoulder
7.2 Knee
7.3 Hand and Wrist
7.4 Elbow
7.5 Foot and Ankle
7.6 Hip
7.7 Groin
7.8 Spine

8 GLOBAL SPORTS MEDICINE MARKET, BY GEOGRAPHY
8.1 North America
8.1.1 US
8.1.2 Canada
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia
8.4 Rest of the World
8.4.1 Latin America
8.4.2 Middle East
8.4.3 Africa
8.4.4 Others

9 KEY DEVELOPMENTS
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 COMPANY PROFILING
10.1 Arthrex
10.2 Biomet Inc.
10.3 Arthrocare
10.4 Conmed Corporation
10.5 Stryker Corporation
10.6 Otto Bock Healthcare
10.7 DJO Global
10.8 Zimmer Holdings Inc.
10.9 Smith & Nephews
10.10 Xiros

Inquiry For Buying



Request Sample




Related Reports

Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) - Pipeline Review, H1 2016

May-2016 | Global Markets Direct | Pages : 39 | Code : MRS-65019 | 3500

Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) - Pipeline Review, H1 2016’, provides in depth analysis on Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) targeted pipeline therapeutics. The report provides comprehensive information on the Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor o Read more

Glucagon-Like Peptide 2 Receptor (GLP-2 Receptor or GLP2R) - Pipeline Review, H1 2016

May-2016 | Global Markets Direct | Pages : 49 | Code : MRS-65018 | 3500

Glucagon-Like Peptide 2 Receptor (GLP-2 Receptor or GLP2R) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Glucagon-Like Peptide 2 Receptor (GLP-2 Receptor or GLP2R) - Pipeline Review, H1 2016’, provides in depth analysis on Glucagon-Like Peptide 2 Receptor (GLP-2 Receptor or GLP2R) targeted pipeline therapeutics. The report provides comprehensive information on the Glucagon-Like Peptide 2 Receptor (GLP-2 Receptor or GLP2R), targeted therapeutics, complete with analysis by Read more

Atypical Chemokine Receptor 3 (Chemokine Orphan Receptor 1 or G-Protein Coupled Receptor 159 or G-Protein Coupled Receptor RDC1 Homolog or GPR159 or CXCR7) - Pipeline Review, H1 2016

May-2016 | Global Markets Direct | Pages : 31 | Code : MRS-65017 | 3500

Atypical Chemokine Receptor 3 (Chemokine Orphan Receptor 1 or G-Protein Coupled Receptor 159 or G-Protein Coupled Receptor RDC1 Homolog or GPR159 or CXCR7) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Atypical Chemokine Receptor 3 (Chemokine Orphan Receptor 1 or G-Protein Coupled Receptor 159 or G-Protein Coupled Receptor RDC1 Homolog or GPR159 or CXCR7) - Pipeline Review, H1 2016’, provides in depth analysis on Atypical Chemokine Receptor 3 (Chemokine Orphan Receptor 1 or Read more

C-X-C Chemokine Receptor Type 1 (CDw128a or High Affinity Interleukin-8 Receptor A or IL-8 Receptor Type 1 or CD181 or CXCR1) - Pipeline Review, H1 2016

May-2016 | Global Markets Direct | Pages : 46 | Code : MRS-65016 | 3500

C-X-C Chemokine Receptor Type 1 (CDw128a or High Affinity Interleukin-8 Receptor A or IL-8 Receptor Type 1 or CD181 or CXCR1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘C-X-C Chemokine Receptor Type 1 (CDw128a or High Affinity Interleukin-8 Receptor A or IL-8 Receptor Type 1 or CD181 or CXCR1) - Pipeline Review, H1 2016’, provides in depth analysis on C-X-C Chemokine Receptor Type 1 (CDw128a or High Affinity Interleukin-8 Receptor A or IL-8 Receptor Type 1 or CD181 or CX Read more

C-C Chemokine Receptor Type 4 (C-C CKR-4 or K5-5 or CD194 or CCR4) - Pipeline Review, H1 2016

May-2016 | Global Markets Direct | Pages : 45 | Code : MRS-65015 | 3500

C-C Chemokine Receptor Type 4 (C-C CKR-4 or K5-5 or CD194 or CCR4) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘C-C Chemokine Receptor Type 4 (C-C CKR-4 or K5-5 or CD194 or CCR4) - Pipeline Review, H1 2016’, provides in depth analysis on C-C Chemokine Receptor Type 4 (C-C CKR-4 or K5-5 or CD194 or CCR4) targeted pipeline therapeutics. The report provides comprehensive information on the C-C Chemokine Receptor Type 4 (C-C CKR-4 or K5-5 or CD194 or CCR4), targeted therapeu Read more

C-C Chemokine Receptor Type 3 (C-C CKR-3 or Eosinophil Eotaxin Receptor or CD193 or CCR3) - Pipeline Review, H1 2016

May-2016 | Global Markets Direct | Pages : 37 | Code : MRS-65014 | 3500

C-C Chemokine Receptor Type 3 (C-C CKR-3 or Eosinophil Eotaxin Receptor or CD193 or CCR3) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘C-C Chemokine Receptor Type 3 (C-C CKR-3 or Eosinophil Eotaxin Receptor or CD193 or CCR3) - Pipeline Review, H1 2016’, provides in depth analysis on C-C Chemokine Receptor Type 3 (C-C CKR-3 or Eosinophil Eotaxin Receptor or CD193 or CCR3) targeted pipeline therapeutics. The report provides comprehensive information on the C-C Chemokine Re Read more

C-C Chemokine Receptor Type 1 (HM145 or LD78 Receptor or Macrophage Inflammatory Protein 1-Alpha Receptor or CD191 or CCR1) - Pipeline Review, H1 2016

May-2016 | Global Markets Direct | Pages : 38 | Code : MRS-65013 | 3500

C-C Chemokine Receptor Type 1 (HM145 or LD78 Receptor or Macrophage Inflammatory Protein 1-Alpha Receptor or CD191 or CCR1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘C-C Chemokine Receptor Type 1 (HM145 or LD78 Receptor or Macrophage Inflammatory Protein 1-Alpha Receptor or CD191 or CCR1) - Pipeline Review, H1 2016’, provides in depth analysis on C-C Chemokine Receptor Type 1 (HM145 or LD78 Receptor or Macrophage Inflammatory Protein 1-Alpha Receptor or CD191 or CCR1) t Read more

Type-2 Angiotensin II Receptor (Angiotensin II Type-2 Receptor or AT2 or AGTR2) - Pipeline Review, H1 2016

May-2016 | Global Markets Direct | Pages : 48 | Code : MRS-65012 | 3500

Type-2 Angiotensin II Receptor (Angiotensin II Type-2 Receptor or AT2 or AGTR2) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Type-2 Angiotensin II Receptor (Angiotensin II Type-2 Receptor or AT2 or AGTR2) - Pipeline Review, H1 2016’, provides in depth analysis on Type-2 Angiotensin II Receptor (Angiotensin II Type-2 Receptor or AT2 or AGTR2) targeted pipeline therapeutics. The report provides comprehensive information on the Type-2 Angiotensin II Receptor (Angiotensin II Read more

Folate Receptor Alpha (Adult Folate Binding Protein or Folate Receptor 1 or KB Cells FBP or Ovarian Tumor Associated Antigen MOv18 or FOLR1) - Pipeline Review, H1 2016

May-2016 | Global Markets Direct | Pages : 44 | Code : MRS-65011 | 3500

Folate Receptor Alpha (Adult Folate Binding Protein or Folate Receptor 1 or KB Cells FBP or Ovarian Tumor Associated Antigen MOv18 or FOLR1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Folate Receptor Alpha (Adult Folate Binding Protein or Folate Receptor 1 or KB Cells FBP or Ovarian Tumor Associated Antigen MOv18 or FOLR1) - Pipeline Review, H1 2016’, provides in depth analysis on Folate Receptor Alpha (Adult Folate Binding Protein or Folate Receptor 1 or KB Cells FBP or Read more

ATP Binding Cassette Sub Family A Member 1 (ATP Binding Cassette Transporter 1 or ABC 1 or ATP Binding Cassette 1 or Cholesterol Efflux Regulatory Protein or ABCA1) - Pipeline Review, H1 2016

May-2016 | Global Markets Direct | Pages : 51 | Code : MRS-65010 | 3500

ATP Binding Cassette Sub Family A Member 1 (ATP Binding Cassette Transporter 1 or ABC 1 or ATP Binding Cassette 1 or Cholesterol Efflux Regulatory Protein or ABCA1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘ATP Binding Cassette Sub Family A Member 1 (ATP Binding Cassette Transporter 1 or ABC 1 or ATP Binding Cassette 1 or Cholesterol Efflux Regulatory Protein or ABCA1) - Pipeline Review, H1 2016’, provides in depth analysis on ATP Binding Cassette Sub Family A Member 1 Read more

Single User | $(USD)4150 View Pricing